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The  year  2014  in the Revista  de GastroenterologÍa  de Méxicolo
v
t
p
p
b
f
t
t
z
i
b
a
a
W
l
w
t
r
a
p
d
c
s
w
o
N
s
t
tEl  an˜o  2014  en  la  Revista  de  Gastroentero
2014  has  been  a  very  interesting  year  for  the  Revista  de  Gas-
troenterología  de  México, with  the  publication  of  innovative
and  up-to-date  articles  spanning  the  entire  spectrum  of  gas-
troenterology.
In  regard  to  the  original  articles  published,  the  studies  on
genes  associated  with  colon  cancer  in  Mexico  and  Colombia
stand  out.1 The  former,  conducted  in  Veracruz-Mexico,  ana-
lyzed  the  survival  rate  in  patients  with  the  mutated  K-ras
gene  compared  with  those  possessing  the  wild-type
K-ras  gene  and  found  no  differences  between  the  two
groups.1 Even  though  the  results  are  related  to  the  small
sample  size,  it  is  signiﬁcant  that  this  type  of  research  is  being
done  in  Mexico.  The  latter  study,  carried  out  in  Medellin-
Colombia,  analyzed  the  mutations  of  the  APC, K-ras, and
TP53  genes,  not  only  in  patients  with  colorectal  cancer,  but
also  in  those  presenting  with  gastric  cancer.  They  reported
that  the  APC  gene  was  the  most  frequently  mutated  in  all
of  the  patients.  Mutations  were  3-fold  more  common  in
the  colorectal  carcinoma  samples  than  in  the  gastric  cancer
ones,  indicating  the  presence  of  different  genetic  pathways
involved  in  the  development  of  the  two  tumors.2 In  his  edi-
torial  on  this  subject,  Llor  emphasizes  the  importance  of
understanding  the  molecular  mechanisms  involved  in  the
carcinogenic  processes  of  these  tumors,  which  can  modify
patient  treatment,  in  the  so-called  precision  medicine.3
Helicobacter  pylori  (H.  pylori)  has  been  considered  the
prime  risk  factor  for  chronic  gastritis,  ulcer,  and  gastric
cancer,  and  has  been  associated  not  only  with  environmen-
tal,  but  also  bacterial  factors,  and  the  immune  response  to
this  infection.  In  the  current  issue  of  the  journal,  Martínez-
Carrillo  et  al.  reported  that  even  though  the  percentage  of
cells  expressing  IFN- was  not  related  to  H.  pylori  infec-
tion  in  either  of  the  two  study  groups,  it  was  lower  in
the  patients  with  chronic  gastritis  infected  with  H.  pylori
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acAs2m2/cagA-  than  in  those  infected  with  the  other  geno-
ypes;  these  differences  were  not  found  in  the  patients
resenting  with  gastric  cancer.  Whether  the  different  strains
roduce  distinct  grades  of  gastric  inﬂammation  remains  to
e  determined.4 Regarding  treatment,  a systematic  review
ound  that  the  H.  pylori  eradication  rates  with  the  standard
riple  therapies  are  very  low,  under  80%  in  countries  in  which
here  is  a  high  resistance  to  clarithromycin  and  metronida-
ole,  as  is  the  case  in  Latin  America.  This  does  not  appear  to
mprove  with  the  addition  of  bismuth  and  although  there  are
etter  results  with  quinolone-based  therapies,  higher  doses
nd  more  prolonged  treatments  are  required.5
From  the  metabolic  perspective,  obesity  has  been  associ-
ted  with  low-grade  inﬂammation  and  immune  activation.
ith  respect  to  this,  Rojano-Rodríguez  et  al.  described  a
inear  relation  of  CRP  to  weight  and  body  mass  index.  CRP
as  also  signiﬁcantly  reduced  after  gastric  bypass  or  gas-
ric  sleeve  surgery,  but  this  decrease  was  not  linear.6 It
emains  to  be  seen  whether  the  reduction  of  this  marker
fter  surgery  is  also  related  to  a decrease  in  the  risk  for
athologies  associated  with  obesity,  such  as  cardiovascular
iseases.
On  another  topic,  total  serum  calcium  and  albumin-
orrected  calcium  above  7.5  mg/dl  during  the  ﬁrst  24  h  were
hown  to  be  useful  predictors  of  acute  pancreatitis  severity,7
ith  a  sensitivity  and  speciﬁcity  similar  or  superior  to  those
f  other  scales,  including  the  Ranson  and  APACHE-IIscores.
evertheless,  as  Peláez-Luna  points  out,  the  results  of  this
tudy  must  be  validated  and  reproduced,  because  even
hough  calcium  is  a  low-cost  test  that  is  very  accessible  at
he  clinical  level,  it  does  not  have  the  best  likelihood  ratio
hen  moderately  severe  patients  are  taken  into  account,
nd  so  from  the  biostatistical  viewpoint,  does  not  appear  to
e  superior  to  the  currently  available  markers  and  scales.8
In  the  ﬁeld  of  hepatology,  in  this  last  issue  of  2014,
he  clinical  characteristics,  risk  factors,  and  diagnostic
pproach  in  patients  with  giant  and  conventional  hepatic
emangiomas  are  compared.  It  should  be  kept  in  mind
hat  hemangiomas  are  the  benign  hepatic  tumors  most
requently  found  in  daily  practice.  The  study  states  that
iant  hemangiomas  are  more  frequent  in  women  and
 by Masson Doyma México S.A. All rights reserved.
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re  associated  with  oral  contraceptives.  The  majority  of
hese  tumors  are  asymptomatic,  but  in  the  one-third
f  patients  that  manifested  symptoms,  abdominal  pain  was
he  most  frequent  complaint.9 Galicia-Moreno  and  Gutiér-
ez  Reyes  reviewed  the  role  that  oxidative  stress  plays
n  ethanol-induced  liver  damage.  Reactive  oxygen  species
nd  reactive  nitrogen  species  are  molecules  formed  dur-
ng  ethanol  metabolism  that  alter  the  biologic  processes  of
he  liver  and  sensitize  hepatocytes  to  the  proinﬂammatory
ytokines.  Even  though  the  antioxidant  effect  of  substances
uch  as  N-acetylcysteine,  corticoids,  silymarin,  and  meta-
oxine,  among  others,  have  been  studied,  well-designed
rials  are  needed  in  order  to  determine  their  effective-
ess  in  these  patients.10 Likewise,  the  currently  available
iomarkers  have  been  reviewed  in  relation  to  the  study  of
iver  ﬁbrosis.  This  is  an  important  aspect  of  clinical  practice,
iven  that  the  use  of  noninvasive  techniques  would  enable
dequate  diagnosis  and  disease  stage  determination,  and
ould  possibly  evaluate  therapeutic  response.11 In  regard
o  another  theme,  reports  in  the  literature  have  associated
osttransplantation  diabetes  with  acute  liver  rejection,
nfections,  and  other  complications.12 In  their  study,  Builes-
ontan˜o  et  al.  encountered  hyperglycemia  in  94%  of  patients
n  the  ﬁrst  48  h  after  liver  transplantation,  but  this  condi-
ion  was  not  associated  with  a  greater  risk  for  rejection,
nfections,  or  longer  hospital  stay.13 These  results  contradict
hose  previously  described,  as  analyzed  by  Vilatobá  Chapa
n  his  editorial,  and  could  be  related  to  the  retrospective
ature  of  the  study  or  to  the  cut-off  point  the  authors  uti-
ized  (>  140  mg/dl)  for  determining  hyperglycemia;12,13 this
erits  further  investigation.
In  relation  to  irritable  bowel  syndrome  (IBS),  an  extensive
vidence-based  review  has  concluded  that  the  microbiota
f  these  patients  is  different  from  that  of  the  controls,
ut  a  microbiota  that  is  characteristic  of  patients  with  this
unctional  bowel  disorder  has  yet  to  be  established;  this  is
ossibly  due  to  the  diversity  of  methods  used  in  the  studies
r  to  limitations  in  the  sequencing  techniques.  The  future
ill  determine  whether  an  IBS-speciﬁc  microbiota  can  be
dentiﬁed  through  the  use  of  «next  generation» and  other
ovel  technologies.  There  is  also  a  need  for  well-designed
tudies  to  establish  if  differences  in  low-grade  inﬂamma-
ion  exist  between  patients  presenting  with  post-infectious
BS  and  those  with  idiopathic  IBS.14 A  study  in  the  area
f  pediatric  gastroenterology  reported  on  the  importance
f  determining  the  presence  of  gastroesophageal  reﬂux  in
hildren  that  are  allergic  to  cow’s  milk,  given  that  the  symp-
oms  of  these  two  entities  are  similar  and  one-third  of  the
atients  presenting  with  this  allergy  also  had  gastroesopha-
eal  reﬂux.15
Concerning  novel  endoscopic  techniques,  the  results  of
 report  on  the  usefulness  of  the  EndoLifter  for  endoscopic
issection  of  the  submucosa  in  a  porcine  model  included  a
igh  success  rate  and  short  surgery  duration.  This  device
acilitates  dissection  by  reducing  the  number  of  injections
nto  the  submucosal  space,  preventing  deeper  dissections;
t  also  enables  traction  and  allows  surgical  instruments  to  be
irected  into  the  desired  area  with  precision.16 Likewise,  the
se  of  elastography  can  improve  the  diagnostic  accuracy  of
ndoscopic  ultrasound  and  ﬁne-needle  aspiration  biopsy  in
he  evaluation  of  pancreatic  lesions.17 And  in  the  realm  of
eaching,  a  study  conducted  in  Argentina  showed  that  theEDITORIAL
upervised  participation  of  residents-in-training  in  colonos-
opies  had  a  positive  impact  on  the  detection  of  adenomas
n  these  procedures.18
Finally,  our  journal  has  been  characterized  by  the  con-
tant  publication  of  clinical  cases,  case  series  of  patients,
cientiﬁc  letters,  and  clinical  images,  all  of  which  are  useful
o  the  clinician  who  confronts  a  wide  spectrum  of  gastroen-
erologic  problems  in  the  daily  management  of  his  or  her
atients.  In  addition,  the  Revista  de  Gastroenterología de  México  is
ow  a  bilingual  journal,  published  simultaneously  in  Span-
sh  and  English.  All  articles  can  be  accessed  online  directly
hrough  PubMed,  making  our  journal  available  to  a  world-
ide  audience,  and  most  certainly,  increasing  its  impact
actor.
And  so  2014  is  coming  to  an  end,  the  last  year  in  the
riennium  of  a  great  concerted  effort  to  turn  the  Revista  de  Gas-
roenterología  de  México  into  a  journal  of  excellent  quality,  and
ithout  a  doubt,  a  leader  in  the  speciality  in  Latin  America.
 promising  future  lies  ahead. .  ..
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